BofA analyst Adam Ron raised the firm’s price target on Oscar Health to $25 from $22 and keeps a Buy rating on the shares after having met with Oscar CFO Scott Blackley at the firm’s Healthcare Conference. Following the meet-up, the firm is raising its price target on higher confidence based on increased confidence in utilization trends, the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OSCR: